COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.

<h4>Background</h4>The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in guiding disease-modifying treatment (DMT).<h4>Objective</h4>To characterize the prevalence and outcome of COVID-19...

Full description

Bibliographic Details
Main Authors: Gabriel Bsteh, Hamid Assar, Harald Hegen, Bettina Heschl, Fritz Leutmezer, Franziska Di Pauli, Christiane Gradl, Gerhard Traxler, Gudrun Zulehner, Paulus Rommer, Peter Wipfler, Michael Guger, Christian Enzinger, Thomas Berger, AUT-MuSC investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0255316

Internet

https://doi.org/10.1371/journal.pone.0255316

Similar Items